Sanara MedTech appoints Zachary Fleming as CEO effective Jan 1, 2022; grants 10,000 RSUs

Sanara MedTech Inc.

Board appointed Zachary B. Fleming as CEO, effective January 1, 2022.
Granted one-time restricted stock award of 10,000 shares of common stock.
Shares vest in three equal installments on Jan 1, 2023, 2024, and 2025.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Zachary B. Fleming

Chief Executive Officer

SMTI · Sanara MedTech Inc.

Effective: 2022-01-01
Filed: January 6, 2022, 6:59 PM ET

appointed Mr. Zachary B. Fleming as the Chief Executive Officer of the Company, effective January 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Zachary B. Fleming was appointed as Chief Executive Officer at Sanara MedTech Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

appointed Mr. Zachary B. Fleming as the Chief Executive Officer of the Company, effective January 1, 2022.

View on SEC.gov

Sanara MedTech Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-000557

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.